Oncology
Immune Checkpoint Inhibitor Combination Efficacious for Patients With High-grade Neuroendocrine Carcinoma
Latest in Endocrinology
Reuters Health • The Doctor's Channel Daily Newscast
Hb A1C levels slightly lower with oral antiglycemics
Jun 1, 2010
| Diabetes, Endocrinology, Family Medicine, Internal Medicine, Pharmacists, Reuters Health • The Doctor's Channel Newscast
NEW YORK (Reuters Health) – Oral antiglycemic agents have a modest effect on reducing glycated hemoglobin levels in patients with diabetes, suggests a new systematic review published online May 18 in Diabetes Care.
According to the meta-analysis, oral antidiabetic agents (OADs) typically lowered...
Reuters Health • The Doctor's Channel Daily Newscast
Hypothyroid women in 1st trimester need 29% higher levothyroxine dose
May 21, 2010
| Endocrinology, Family Medicine, Internal Medicine, Medical Students, Nurses/NP/PA, Ob/Gyn, Patient Education, Pharmacists, Reuters Health • The Doctor's Channel Newscast, Women’s Health
NEW YORK (Reuters Health) - When hypothyroid women become pregnant, they need to increase their levothyroxine dose by two tablets per week, or 29%, a new trial has shown.
This protocol "significantly reduces the risk of maternal hypothyroidism during the first trimester and mimics normal physiology,"...
Reuters Health • The Doctor's Channel Daily Newscast
For low-carb dieters, statin plus cholesterol uptake inhibitor lowers LDL
May 18, 2010
| Cardiology, Cardiology: Non-Interventional, Endocrinology, Family Medicine, Internal Medicine, Medical Students, Nurses/NP/PA, Patient Education, Pharmacists, Reuters Health • The Doctor's Channel Newscast
NEW YORK (Reuters Health) - The combination of the cholesterol uptake inhibitor ezetimibe and a statin is more effective than a statin alone for reducing LDL cholesterol in people on low-carbohydrate diets, randomized trial data show.
Low-carbohydrate diets improve triglycerides and HDL-cholesterol, but...
Pro-Bites "Protein on the Go!"
Apr 29, 2010
